Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement
Go back to Medtronic and Tandem Diabetes Care Enter Into Patent Cross-License Agreement| Medtronic Inc. (NYSE: MDT) | Delayed: 90.96 -0.66 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.62 | 52 Week High | $89.27 | |||
| Open | $93.00 | 52 Week Low | $71.03 | |||
| Day High | $93.00 | P/E | 25.84 | |||
| Day Low | $90.26 | EPS | $3.52 | |||
| Volume | 5,408,535 | |||||
| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 17.11 -1.2 (6.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.31 | 52 Week High | $12.48 | |||
| Open | $18.48 | 52 Week Low | $1.60 | |||
| Day High | $18.67 | P/E | N/A | |||
| Day Low | $17.07 | EPS | $-6.33 | |||
| Volume | 1,789,046 | |||||
